Physical Rehabilitation in Patients with Guillain-Barré Syndrome Associated with COVID-19 in Ecuador: A Descriptive Cross-Sectional Study

Authors

Abstract

Introduction: The COVID-19 pandemic has highlighted neurological complications such as Guillain-Barré syndrome (GBS), increasing demand for physical rehabilitation services crucial for functional recovery in these patients.

Objective: To analyze the geographical distribution and prevalence of COVID-19-associated GBS and related physical rehabilitation procedures in Ecuador during 2020-2022.

Methods: A descriptive cross-sectional study was conducted that included clinical records of diagnoses related to nervous system infections (ICD-10: A80-A88) and pneumocystosis (B59), as well as physiotherapy procedures in Ecuadorian public and private health institutions. Descriptive statistical analysis, choropleth maps, and comparative prevalence tests were used.

Results: A total of 163 central nervous system infection cases were identified, with unspecified viral encephalitis being the most frequent diagnosis (54 %). Physical rehabilitation showed high concentration in densely populated provinces such as Pichincha (28 %) and Guayas (15 %), with therapeutic exercises being the most performed procedure (51.6 %). A significant territorial disparity was observed in service provision and accessibility, particularly restricted in Amazonian and insular regions.

Conclusions: The pandemic has intensified existing disparities in the provision of physiotherapy services in Ecuador, underscoring an urgent need to improve public policies and equitable resource distribution. These findings guide future research and strategies to enhance comprehensive care for patients affected by COVID-19-associated GBS.

Downloads

Download data is not yet available.

Published

2025-07-15

How to Cite

1.
Madrid Peralta PF. Physical Rehabilitation in Patients with Guillain-Barré Syndrome Associated with COVID-19 in Ecuador: A Descriptive Cross-Sectional Study. Rev Cubana Inv Bioméd [Internet]. 2025 Jul. 15 [cited 2025 Jul. 19];44. Available from: https://revibiomedica.sld.cu/index.php/ibi/article/view/3893